0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538
Global Neurological Biomarkers Market Insights, Forecast to 2025
Published Date: May 2019
|
Report Code: QYRE-Auto-515
Home | Category |Business & Industrial |Pharmaceuticals & Biotech
Global Neurological Biomarkers Market Insights Forecast to 2025

Global Neurological Biomarkers Market Insights, Forecast to 2025

Code: QYRE-Auto-515
Report
May 2019
122 Pages
QYResearch
Region: Global, Europe, North America, Middle East, Asia Pacific,
Description
Table of Content
Tables & Figures

NEUROLOGICAL BIOMARKERS MARKET OVERVIEW: 2025

The global Neurological Biomarkers market is valued at 4710 million US$ in 2018 and will reach 8950 million US$ by the end of 2025, growing at a CAGR of 9.6% during 2019-2025.
 A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.
 
The classification of Neurological Biomarkers includes Proteomics, Genomics, Imaging, Bioinformatics and others, and the proportion of Proteomics in 2017 is about 31%.
 
Neurological Biomarkers is widely used in Diagnostics, Drug Discovery, Personalized Medicine and other field. The most proportion of Neurological Biomarkers is used for Diagnostics, and the revenue in 2017 is 1.35 billion USD.
 
North America is the largest consumption place, with a consumption market share nearly 57% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
 
The objectives of this study are to define, segment, and project the size of the Neurological Biomarkers market based on company, product type, end user and key regions.
 
This report studies the global market size of Neurological Biomarkers in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Neurological Biomarkers in these regions.
 
This research report categorizes the global Neurological Biomarkers market by top players/brands, region, type and end user. This report also studies the global Neurological Biomarkers market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
 
 
THE FOLLOWING MANUFACTURERS ARE COVERED IN THIS REPORT, WITH SALES, REVENUE, MARKET SHARE FOR EACH COMPANY:
  • Thermo Fisher Scientific
  • Merck
  • Quest Diagnostics
  • Abbott
  • Roche
  • Illumina
  • Bio-Rad Laboratories
  • QIAGEN
  • Myriad RBM
  • Cisbio Bioassays
  • Athena Diagnostics
  • BGI
  • Wuxi APP
  • Aepodia
  • Proteome Sciences
  • Genewiz
 
 
MARKET SIZE BY PRODUCT
  • Proteomics
  • Genomics
  • Imaging
  • Bioinformatics
  • Others
 
MARKET SIZE BY END USER  
  • Diagnostics
  • Drug Discovery
  • Personalized Medicine
  • Others
 
MARKET SIZE BY REGION
  • North America
      • United States
      • Canada
      • Mexico
  • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
      • Indonesia
      • Singapore
      • Malaysia
      • Philippines
      • Thailand
      • Vietnam
  • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Russia
  • Central & South America
      • Brazil
      • Rest of Central & South America
  • Middle East & Africa
    • GCC Countries
    • Turkey
    • Egypt
    • South Africa
 
THE STUDY OBJECTIVES OF THIS REPORT ARE:
  • To study and analyze the global Neurological Biomarkers market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
  • To understand the structure of Neurological Biomarkers market by identifying its various subsegments.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • Focuses on the key global Neurological Biomarkers companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
  • To project the value and sales volume of Neurological Biomarkers submarkets, with respect to key regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
 
In this study, the years considered to estimate the market size of Neurological Biomarkers are as follows:
  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025
 
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Neurological Biomarkers market, to estimate the size of various other dependent submarkets in the overall market.
 
Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
 
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
 
1 Study Coverage
    1.1 Neurological Biomarkers Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Neurological Biomarkers Market Size Growth Rate by Product
        1.4.2 Proteomics
        1.4.3 Genomics
        1.4.4 Imaging
        1.4.5 Bioinformatics
        1.4.6 Others
    1.5 Market by End User
        1.5.1 Global Neurological Biomarkers Market Size Growth Rate by End User
        1.5.2 Diagnostics
        1.5.3 Drug Discovery
        1.5.4 Personalized Medicine
        1.5.5 Others
    1.6 Study Objectives
    1.7 Years Considered
 
2 Executive Summary
    2.1 Global Neurological Biomarkers Market Size
        2.1.1 Global Neurological Biomarkers Revenue 2014-2025
        2.1.2 Global Neurological Biomarkers Sales 2014-2025
    2.2 Neurological Biomarkers Growth Rate by Regions
        2.2.1 Global Neurological Biomarkers Sales by Regions
        2.2.2 Global Neurological Biomarkers Revenue by Regions
 
3 Breakdown Data by Manufacturers
    3.1 Neurological Biomarkers Sales by Manufacturers
        3.1.1 Neurological Biomarkers Sales by Manufacturers
        3.1.2 Neurological Biomarkers Sales Market Share by Manufacturers
        3.1.3 Global Neurological Biomarkers Market Concentration Ratio (CR5 and HHI)
    3.2 Neurological Biomarkers Revenue by Manufacturers
        3.2.1 Neurological Biomarkers Revenue by Manufacturers (2014-2019)
        3.2.2 Neurological Biomarkers Revenue Share by Manufacturers (2014-2019)
    3.3 Neurological Biomarkers Price by Manufacturers
    3.4 Neurological Biomarkers Manufacturing Base Distribution, Product Types
        3.4.1 Neurological Biomarkers Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Neurological Biomarkers Product Type
        3.4.3 Date of International Manufacturers Enter into Neurological Biomarkers Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
 
4 Breakdown Data by Product
    4.1 Global Neurological Biomarkers Sales by Product
    4.2 Global Neurological Biomarkers Revenue by Product
    4.3 Neurological Biomarkers Price by Product
 
5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Neurological Biomarkers Breakdown Data by End User
 
6 North America
    6.1 North America Neurological Biomarkers by Countries
        6.1.1 North America Neurological Biomarkers Sales by Countries
        6.1.2 North America Neurological Biomarkers Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Neurological Biomarkers by Product
    6.3 North America Neurological Biomarkers by End User
 
7 Europe
    7.1 Europe Neurological Biomarkers by Countries
        7.1.1 Europe Neurological Biomarkers Sales by Countries
        7.1.2 Europe Neurological Biomarkers Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Neurological Biomarkers by Product
    7.3 Europe Neurological Biomarkers by End User
 
8 Asia Pacific
    8.1 Asia Pacific Neurological Biomarkers by Countries
        8.1.1 Asia Pacific Neurological Biomarkers Sales by Countries
        8.1.2 Asia Pacific Neurological Biomarkers Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Neurological Biomarkers by Product
    8.3 Asia Pacific Neurological Biomarkers by End User
 
9 Central & South America
    9.1 Central & South America Neurological Biomarkers by Countries
        9.1.1 Central & South America Neurological Biomarkers Sales by Countries
        9.1.2 Central & South America Neurological Biomarkers Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Neurological Biomarkers by Product
    9.3 Central & South America Neurological Biomarkers by End User
 
10 Middle East and Africa
    10.1 Middle East and Africa Neurological Biomarkers by Countries
        10.1.1 Middle East and Africa Neurological Biomarkers Sales by Countries
        10.1.2 Middle East and Africa Neurological Biomarkers Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Neurological Biomarkers by Product
    10.3 Middle East and Africa Neurological Biomarkers by End User
 
11 Company Profiles
    11.1 Thermo Fisher Scientific
        11.1.1 Thermo Fisher Scientific Company Details
        11.1.2 Company Business Overview
        11.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 Thermo Fisher Scientific Neurological Biomarkers Products Offered
        11.1.5 Thermo Fisher Scientific Recent Development
    11.2 Merck
        11.2.1 Merck Company Details
        11.2.2 Company Business Overview
        11.2.3 Merck Neurological Biomarkers Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Merck Neurological Biomarkers Products Offered
        11.2.5 Merck Recent Development
    11.3 Quest Diagnostics
        11.3.1 Quest Diagnostics Company Details
        11.3.2 Company Business Overview
        11.3.3 Quest Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 Quest Diagnostics Neurological Biomarkers Products Offered
        11.3.5 Quest Diagnostics Recent Development
    11.4 Abbott
        11.4.1 Abbott Company Details
        11.4.2 Company Business Overview
        11.4.3 Abbott Neurological Biomarkers Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Abbott Neurological Biomarkers Products Offered
        11.4.5 Abbott Recent Development
    11.5 Roche
        11.5.1 Roche Company Details
        11.5.2 Company Business Overview
        11.5.3 Roche Neurological Biomarkers Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Roche Neurological Biomarkers Products Offered
        11.5.5 Roche Recent Development
    11.6 Illumina
        11.6.1 Illumina Company Details
        11.6.2 Company Business Overview
        11.6.3 Illumina Neurological Biomarkers Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 Illumina Neurological Biomarkers Products Offered
        11.6.5 Illumina Recent Development
    11.7 Bio-Rad Laboratories
        11.7.1 Bio-Rad Laboratories Company Details
        11.7.2 Company Business Overview
        11.7.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue and Gross Margin (2014-2019)
        11.7.4 Bio-Rad Laboratories Neurological Biomarkers Products Offered
        11.7.5 Bio-Rad Laboratories Recent Development
    11.8 QIAGEN
        11.8.1 QIAGEN Company Details
        11.8.2 Company Business Overview
        11.8.3 QIAGEN Neurological Biomarkers Sales, Revenue and Gross Margin (2014-2019)
        11.8.4 QIAGEN Neurological Biomarkers Products Offered
        11.8.5 QIAGEN Recent Development
    11.9 Myriad RBM
        11.9.1 Myriad RBM Company Details
        11.9.2 Company Business Overview
        11.9.3 Myriad RBM Neurological Biomarkers Sales, Revenue and Gross Margin (2014-2019)
        11.9.4 Myriad RBM Neurological Biomarkers Products Offered
        11.9.5 Myriad RBM Recent Development
    11.10 Cisbio Bioassays
        11.10.1 Cisbio Bioassays Company Details
        11.10.2 Company Business Overview
        11.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue and Gross Margin (2014-2019)
        11.10.4 Cisbio Bioassays Neurological Biomarkers Products Offered
        11.10.5 Cisbio Bioassays Recent Development
    11.11 Athena Diagnostics
    11.12 BGI
    11.13 Wuxi APP
    11.14 Aepodia
    11.15 Proteome Sciences
    11.16 Genewiz
 
12 Future Forecast
    12.1 Neurological Biomarkers Market Forecast by Regions
        12.1.1 Global Neurological Biomarkers Sales Forecast by Regions 2019-2025
        12.1.2 Global Neurological Biomarkers Revenue Forecast by Regions 2019-2025
    12.2 Neurological Biomarkers Market Forecast by Product
        12.2.1 Global Neurological Biomarkers Sales Forecast by Product 2019-2025
        12.2.2 Global Neurological Biomarkers Revenue Forecast by Product 2019-2025
    12.3 Neurological Biomarkers Market Forecast by End User
    12.4 North America Neurological Biomarkers Forecast
    12.5 Europe Neurological Biomarkers Forecast
    12.6 Asia Pacific Neurological Biomarkers Forecast
    12.7 Central & South America Neurological Biomarkers Forecast
    12.8 Middle East and Africa Neurological Biomarkers Forecast
 
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators
 
14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Neurological Biomarkers Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors
 
15 Research Findings and Conclusion
 
16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables and Figures
 
    Figure Neurological Biomarkers Product Picture
    Table Neurological Biomarkers Market Segments
    Table Key Manufacturers Neurological Biomarkers Covered
    Table Global Neurological Biomarkers Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
    Figure Global Neurological Biomarkers Sales Market Share by Product 2014-2025
    Figure Proteomics Product Picture
    Table Major Manufacturers of Proteomics
    Figure Genomics Product Picture
    Table Major Manufacturers of Genomics
    Figure Imaging Product Picture
    Table Major Manufacturers of Imaging
    Figure Bioinformatics Product Picture
    Table Major Manufacturers of Bioinformatics
    Figure Others Product Picture
    Table Major Manufacturers of Others
    Table Global Neurological Biomarkers Market Size Growth Rate by End User 2019-2025 (K Units)
    Figure Diagnostics
    Figure Drug Discovery
    Figure Personalized Medicine
    Figure Others
    Figure Neurological Biomarkers Report Years Considered
    Figure Global Neurological Biomarkers Market Size 2014-2025 (Million US$)
    Figure Global Neurological Biomarkers Sales 2014-2025 (K Units)
    Table Global Neurological Biomarkers Market Size by Regions 2014-2019 (K Units) & (Million US$)
    Table Global Neurological Biomarkers Sales by Regions 2014-2019 (K Units)
    Table Global Neurological Biomarkers Sales Market Share by Regions 2014-2019
    Figure Global Neurological Biomarkers Sales Market Share by Regions 2014-2019
    Figure 2018 Global Neurological Biomarkers Sales Market Share by Regions
    Table Global Neurological Biomarkers Revenue by Regions 2014-2019 (Million US$)
    Table Global Neurological Biomarkers Revenue Market Share by Regions 2014-2019
    Figure Global Neurological Biomarkers Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Neurological Biomarkers Revenue Market Share by Regions
    Table Global Neurological Biomarkers Sales by Manufacturers (2014-2019) (K Units)
    Table Global Neurological Biomarkers Sales Share by Manufacturers (2014-2019)
    Figure Global Neurological Biomarkers Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Neurological Biomarkers Revenue by Manufacturers (2014-2019) (Million USD)
    Table Neurological Biomarkers Revenue Share by Manufacturers (2014-2019)
    Figure Neurological Biomarkers Value Share by Manufacturers in 2018
    Table Key Manufacturers Neurological Biomarkers Price (2014-2019) (USD/Unit)
    Table Neurological Biomarkers Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Neurological Biomarkers Product Type
    Table Date of International Manufacturers Enter into Neurological Biomarkers Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Neurological Biomarkers Sales by Product (2014-2019) (K Units)
    Table Global Neurological Biomarkers Sales Share by Product (2014-2019)
    Figure Global Neurological Biomarkers Sales Market Share by Product (2014-2019)
    Figure Global Neurological Biomarkers Sales Market Share by Product in 2018
    Table Global Neurological Biomarkers Revenue by Product (2014-2019) (Million US$)
    Table Global Neurological Biomarkers Revenue Share by Product (2014-2019)
    Figure Global Neurological Biomarkers Revenue Market Share by Product (2014-2019)
    Figure Global Neurological Biomarkers Revenue Market Share by Product in 2018
    Table Neurological Biomarkers Price by Product 2014-2019 (USD/Unit)
    Table Global Neurological Biomarkers Sales by End User (2014-2019) (K Units)
    Table Global Neurological Biomarkers Sales Share by End User (2014-2019)
    Figure Global Sales Neurological Biomarkers Market Share by End User (2014-2019)
    Figure Global Sales Neurological Biomarkers Market Share by End User in 2018
    Figure North America Neurological Biomarkers Sales Growth Rate 2014-2019 (K Units)
    Figure North America Neurological Biomarkers Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Neurological Biomarkers Sales by Countries (2014-2019) (K Units)
    Table North America Neurological Biomarkers Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Neurological Biomarkers Sales Market Share by Countries
    Table North America Neurological Biomarkers Revenue by Countries (2014-2019) (Million US$)
    Table North America Neurological Biomarkers Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Neurological Biomarkers Revenue Market Share by Countries
    Figure United States Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure United States Neurological Biomarkers Revenue Growth Rate (2014-2019) (K Units)
    Figure Canada Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Canada Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Mexico Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Neurological Biomarkers Sales by Product (2014-2019) (K Units)
    Table North America Neurological Biomarkers Sales Market Share by Product (2014-2019)
    Figure 2018 North America Neurological Biomarkers Market Share by Product
    Table North America Neurological Biomarkers Sales by End User (2014-2019) (K Units)
    Table North America Neurological Biomarkers Sales Market Share by End User (2014-2019)
    Figure 2018 North America Neurological Biomarkers Market Share by End User
    Figure Europe Neurological Biomarkers Sales Growth Rate 2014-2019 (K Units)
    Figure Europe Neurological Biomarkers Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Neurological Biomarkers Sales by Countries (2014-2019) (K Units)
    Table Europe Neurological Biomarkers Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Neurological Biomarkers Sales Market Share by Countries
    Table Europe Neurological Biomarkers Revenue by Countries (2014-2019) (Million US$)
    Table Europe Neurological Biomarkers Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Neurological Biomarkers Revenue Market Share by Countries
    Figure Germany Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Germany Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure France Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure UK Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Italy Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Russia Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Neurological Biomarkers Sales by Product (2014-2019) (K Units)
    Table Europe Neurological Biomarkers Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Neurological Biomarkers Market Share by Product
    Table Europe Neurological Biomarkers Sales by End User (2014-2019) (K Units)
    Table Europe Neurological Biomarkers Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Neurological Biomarkers Market Share by End User
    Figure Asia Pacific Neurological Biomarkers Sales Growth Rate 2014-2019 (K Units)
    Figure Asia Pacific Neurological Biomarkers Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Neurological Biomarkers Sales by Countries (2014-2019) (K Units)
    Table Asia Pacific Neurological Biomarkers Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Neurological Biomarkers Sales Market Share by Countries
    Table Asia Pacific Neurological Biomarkers Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Neurological Biomarkers Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Neurological Biomarkers Revenue Market Share by Countries
    Figure China Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure China Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Japan Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Korea Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure India Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Australia Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Indonesia Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Malaysia Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Philippines Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Thailand Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Vietnam Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Singapore Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Neurological Biomarkers Sales by Product (2014-2019) (K Units)
    Table Asia Pacific Neurological Biomarkers Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Neurological Biomarkers Market Share by Product
    Table Asia Pacific Neurological Biomarkers Sales by End User (2014-2019) (K Units)
    Table Asia Pacific Neurological Biomarkers Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Neurological Biomarkers Market Share by End User
    Figure Central & South America Neurological Biomarkers Sales Growth Rate 2014-2019 (K Units)
    Figure Central & South America Neurological Biomarkers Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Neurological Biomarkers Sales by Countries (2014-2019) (K Units)
    Table Central & South America Neurological Biomarkers Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Neurological Biomarkers Sales Market Share by Countries
    Table Central & South America Neurological Biomarkers Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Neurological Biomarkers Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Neurological Biomarkers Revenue Market Share by Countries
    Figure Brazil Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Brazil Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Argentina Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Neurological Biomarkers Sales by Product (2014-2019) (K Units)
    Table Central & South America Neurological Biomarkers Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Neurological Biomarkers Market Share by Product
    Table Central & South America Neurological Biomarkers Sales by End User (2014-2019) (K Units)
    Table Central & South America Neurological Biomarkers Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Neurological Biomarkers Market Share by End User
    Figure Middle East and Africa Neurological Biomarkers Sales Growth Rate 2014-2019 (K Units)
    Figure Middle East and Africa Neurological Biomarkers Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Neurological Biomarkers Sales by Countries (2014-2019) (K Units)
    Table Middle East and Africa Neurological Biomarkers Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Neurological Biomarkers Sales Market Share by Countries
    Table Middle East and Africa Neurological Biomarkers Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Neurological Biomarkers Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Neurological Biomarkers Revenue Market Share by Countries
    Figure GCC Countries Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure GCC Countries Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Turkey Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Egypt Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure South Africa Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Neurological Biomarkers Sales by Product (2014-2019) (K Units)
    Table Middle East and Africa Neurological Biomarkers Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Neurological Biomarkers Market Share by Product
    Table Middle East and Africa Neurological Biomarkers Sales by End User (2014-2019) (K Units)
    Table Middle East and Africa Neurological Biomarkers Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Neurological Biomarkers Market Share by End User
    Table Thermo Fisher Scientific Company Details
    Table Thermo Fisher Scientific Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Thermo Fisher Scientific Recent Development
    Table Merck Company Details
    Table Merck Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Merck Recent Development
    Table Quest Diagnostics Company Details
    Table Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Quest Diagnostics Recent Development
    Table Abbott Company Details
    Table Abbott Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Abbott Recent Development
    Table Roche Company Details
    Table Roche Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Roche Recent Development
    Table Illumina Company Details
    Table Illumina Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Illumina Recent Development
    Table Bio-Rad Laboratories Company Details
    Table Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Bio-Rad Laboratories Recent Development
    Table QIAGEN Company Details
    Table QIAGEN Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table QIAGEN Recent Development
    Table Myriad RBM Company Details
    Table Myriad RBM Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Myriad RBM Recent Development
    Table Cisbio Bioassays Company Details
    Table Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Cisbio Bioassays Recent Development
    Table Athena Diagnostics Company Details
    Table BGI Company Details
    Table Wuxi APP Company Details
    Table Aepodia Company Details
    Table Proteome Sciences Company Details
    Table Genewiz Company Details
    Table Global Neurological Biomarkers Sales Forecast by Regions 2019-2025 (K Units)
    Table Global Neurological Biomarkers Sales Market Share Forecast by Regions 2019-2025
    Table Global Neurological Biomarkers Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Neurological Biomarkers Revenue Market Share Forecast by Regions 2019-2025
    Table Global Neurological Biomarkers Sales Forecast by Product 2019-2025 (K Units)
    Table Global Neurological Biomarkers Sales Market Share Forecast by Product 2019-2025
    Table Global Neurological Biomarkers Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Neurological Biomarkers Revenue Market Share Forecast by Product 2019-2025
    Table Global Neurological Biomarkers Sales Forecast by End User 2019-2025 (K Units)
    Table Global Neurological Biomarkers Sales Market Share Forecast by End User 2019-2025
    Figure North America Neurological Biomarkers Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure North America Neurological Biomarkers Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Neurological Biomarkers Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Europe Neurological Biomarkers Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Neurological Biomarkers Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Asia Pacific Neurological Biomarkers Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Neurological Biomarkers Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Central & South America Neurological Biomarkers Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Neurological Biomarkers Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Middle East and Africa Neurological Biomarkers Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Neurological Biomarkers Value Chain
    Table Neurological Biomarkers Customers List
    Table Neurological Biomarkers Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

NEUROLOGICAL BIOMARKERS MARKET OVERVIEW: 2025

The global Neurological Biomarkers market is valued at 4710 million US$ in 2018 and will reach 8950 million US$ by the end of 2025, growing at a CAGR of 9.6% during 2019-2025.
 A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.
 
The classification of Neurological Biomarkers includes Proteomics, Genomics, Imaging, Bioinformatics and others, and the proportion of Proteomics in 2017 is about 31%.
 
Neurological Biomarkers is widely used in Diagnostics, Drug Discovery, Personalized Medicine and other field. The most proportion of Neurological Biomarkers is used for Diagnostics, and the revenue in 2017 is 1.35 billion USD.
 
North America is the largest consumption place, with a consumption market share nearly 57% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
 
The objectives of this study are to define, segment, and project the size of the Neurological Biomarkers market based on company, product type, end user and key regions.
 
This report studies the global market size of Neurological Biomarkers in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Neurological Biomarkers in these regions.
 
This research report categorizes the global Neurological Biomarkers market by top players/brands, region, type and end user. This report also studies the global Neurological Biomarkers market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
 
 
THE FOLLOWING MANUFACTURERS ARE COVERED IN THIS REPORT, WITH SALES, REVENUE, MARKET SHARE FOR EACH COMPANY:
  • Thermo Fisher Scientific
  • Merck
  • Quest Diagnostics
  • Abbott
  • Roche
  • Illumina
  • Bio-Rad Laboratories
  • QIAGEN
  • Myriad RBM
  • Cisbio Bioassays
  • Athena Diagnostics
  • BGI
  • Wuxi APP
  • Aepodia
  • Proteome Sciences
  • Genewiz
 
 
MARKET SIZE BY PRODUCT
  • Proteomics
  • Genomics
  • Imaging
  • Bioinformatics
  • Others
 
MARKET SIZE BY END USER  
  • Diagnostics
  • Drug Discovery
  • Personalized Medicine
  • Others
 
MARKET SIZE BY REGION
  • North America
      • United States
      • Canada
      • Mexico
  • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
      • Indonesia
      • Singapore
      • Malaysia
      • Philippines
      • Thailand
      • Vietnam
  • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Russia
  • Central & South America
      • Brazil
      • Rest of Central & South America
  • Middle East & Africa
    • GCC Countries
    • Turkey
    • Egypt
    • South Africa
 
THE STUDY OBJECTIVES OF THIS REPORT ARE:
  • To study and analyze the global Neurological Biomarkers market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
  • To understand the structure of Neurological Biomarkers market by identifying its various subsegments.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • Focuses on the key global Neurological Biomarkers companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
  • To project the value and sales volume of Neurological Biomarkers submarkets, with respect to key regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
 
In this study, the years considered to estimate the market size of Neurological Biomarkers are as follows:
  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025
 
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Neurological Biomarkers market, to estimate the size of various other dependent submarkets in the overall market.
 
Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
 
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Read More
Table of Contents
 
1 Study Coverage
    1.1 Neurological Biomarkers Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Neurological Biomarkers Market Size Growth Rate by Product
        1.4.2 Proteomics
        1.4.3 Genomics
        1.4.4 Imaging
        1.4.5 Bioinformatics
        1.4.6 Others
    1.5 Market by End User
        1.5.1 Global Neurological Biomarkers Market Size Growth Rate by End User
        1.5.2 Diagnostics
        1.5.3 Drug Discovery
        1.5.4 Personalized Medicine
        1.5.5 Others
    1.6 Study Objectives
    1.7 Years Considered
 
2 Executive Summary
    2.1 Global Neurological Biomarkers Market Size
        2.1.1 Global Neurological Biomarkers Revenue 2014-2025
        2.1.2 Global Neurological Biomarkers Sales 2014-2025
    2.2 Neurological Biomarkers Growth Rate by Regions
        2.2.1 Global Neurological Biomarkers Sales by Regions
        2.2.2 Global Neurological Biomarkers Revenue by Regions
 
3 Breakdown Data by Manufacturers
    3.1 Neurological Biomarkers Sales by Manufacturers
        3.1.1 Neurological Biomarkers Sales by Manufacturers
        3.1.2 Neurological Biomarkers Sales Market Share by Manufacturers
        3.1.3 Global Neurological Biomarkers Market Concentration Ratio (CR5 and HHI)
    3.2 Neurological Biomarkers Revenue by Manufacturers
        3.2.1 Neurological Biomarkers Revenue by Manufacturers (2014-2019)
        3.2.2 Neurological Biomarkers Revenue Share by Manufacturers (2014-2019)
    3.3 Neurological Biomarkers Price by Manufacturers
    3.4 Neurological Biomarkers Manufacturing Base Distribution, Product Types
        3.4.1 Neurological Biomarkers Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Neurological Biomarkers Product Type
        3.4.3 Date of International Manufacturers Enter into Neurological Biomarkers Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
 
4 Breakdown Data by Product
    4.1 Global Neurological Biomarkers Sales by Product
    4.2 Global Neurological Biomarkers Revenue by Product
    4.3 Neurological Biomarkers Price by Product
 
5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Neurological Biomarkers Breakdown Data by End User
 
6 North America
    6.1 North America Neurological Biomarkers by Countries
        6.1.1 North America Neurological Biomarkers Sales by Countries
        6.1.2 North America Neurological Biomarkers Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Neurological Biomarkers by Product
    6.3 North America Neurological Biomarkers by End User
 
7 Europe
    7.1 Europe Neurological Biomarkers by Countries
        7.1.1 Europe Neurological Biomarkers Sales by Countries
        7.1.2 Europe Neurological Biomarkers Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Neurological Biomarkers by Product
    7.3 Europe Neurological Biomarkers by End User
 
8 Asia Pacific
    8.1 Asia Pacific Neurological Biomarkers by Countries
        8.1.1 Asia Pacific Neurological Biomarkers Sales by Countries
        8.1.2 Asia Pacific Neurological Biomarkers Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Neurological Biomarkers by Product
    8.3 Asia Pacific Neurological Biomarkers by End User
 
9 Central & South America
    9.1 Central & South America Neurological Biomarkers by Countries
        9.1.1 Central & South America Neurological Biomarkers Sales by Countries
        9.1.2 Central & South America Neurological Biomarkers Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Neurological Biomarkers by Product
    9.3 Central & South America Neurological Biomarkers by End User
 
10 Middle East and Africa
    10.1 Middle East and Africa Neurological Biomarkers by Countries
        10.1.1 Middle East and Africa Neurological Biomarkers Sales by Countries
        10.1.2 Middle East and Africa Neurological Biomarkers Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Neurological Biomarkers by Product
    10.3 Middle East and Africa Neurological Biomarkers by End User
 
11 Company Profiles
    11.1 Thermo Fisher Scientific
        11.1.1 Thermo Fisher Scientific Company Details
        11.1.2 Company Business Overview
        11.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 Thermo Fisher Scientific Neurological Biomarkers Products Offered
        11.1.5 Thermo Fisher Scientific Recent Development
    11.2 Merck
        11.2.1 Merck Company Details
        11.2.2 Company Business Overview
        11.2.3 Merck Neurological Biomarkers Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Merck Neurological Biomarkers Products Offered
        11.2.5 Merck Recent Development
    11.3 Quest Diagnostics
        11.3.1 Quest Diagnostics Company Details
        11.3.2 Company Business Overview
        11.3.3 Quest Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 Quest Diagnostics Neurological Biomarkers Products Offered
        11.3.5 Quest Diagnostics Recent Development
    11.4 Abbott
        11.4.1 Abbott Company Details
        11.4.2 Company Business Overview
        11.4.3 Abbott Neurological Biomarkers Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Abbott Neurological Biomarkers Products Offered
        11.4.5 Abbott Recent Development
    11.5 Roche
        11.5.1 Roche Company Details
        11.5.2 Company Business Overview
        11.5.3 Roche Neurological Biomarkers Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Roche Neurological Biomarkers Products Offered
        11.5.5 Roche Recent Development
    11.6 Illumina
        11.6.1 Illumina Company Details
        11.6.2 Company Business Overview
        11.6.3 Illumina Neurological Biomarkers Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 Illumina Neurological Biomarkers Products Offered
        11.6.5 Illumina Recent Development
    11.7 Bio-Rad Laboratories
        11.7.1 Bio-Rad Laboratories Company Details
        11.7.2 Company Business Overview
        11.7.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue and Gross Margin (2014-2019)
        11.7.4 Bio-Rad Laboratories Neurological Biomarkers Products Offered
        11.7.5 Bio-Rad Laboratories Recent Development
    11.8 QIAGEN
        11.8.1 QIAGEN Company Details
        11.8.2 Company Business Overview
        11.8.3 QIAGEN Neurological Biomarkers Sales, Revenue and Gross Margin (2014-2019)
        11.8.4 QIAGEN Neurological Biomarkers Products Offered
        11.8.5 QIAGEN Recent Development
    11.9 Myriad RBM
        11.9.1 Myriad RBM Company Details
        11.9.2 Company Business Overview
        11.9.3 Myriad RBM Neurological Biomarkers Sales, Revenue and Gross Margin (2014-2019)
        11.9.4 Myriad RBM Neurological Biomarkers Products Offered
        11.9.5 Myriad RBM Recent Development
    11.10 Cisbio Bioassays
        11.10.1 Cisbio Bioassays Company Details
        11.10.2 Company Business Overview
        11.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue and Gross Margin (2014-2019)
        11.10.4 Cisbio Bioassays Neurological Biomarkers Products Offered
        11.10.5 Cisbio Bioassays Recent Development
    11.11 Athena Diagnostics
    11.12 BGI
    11.13 Wuxi APP
    11.14 Aepodia
    11.15 Proteome Sciences
    11.16 Genewiz
 
12 Future Forecast
    12.1 Neurological Biomarkers Market Forecast by Regions
        12.1.1 Global Neurological Biomarkers Sales Forecast by Regions 2019-2025
        12.1.2 Global Neurological Biomarkers Revenue Forecast by Regions 2019-2025
    12.2 Neurological Biomarkers Market Forecast by Product
        12.2.1 Global Neurological Biomarkers Sales Forecast by Product 2019-2025
        12.2.2 Global Neurological Biomarkers Revenue Forecast by Product 2019-2025
    12.3 Neurological Biomarkers Market Forecast by End User
    12.4 North America Neurological Biomarkers Forecast
    12.5 Europe Neurological Biomarkers Forecast
    12.6 Asia Pacific Neurological Biomarkers Forecast
    12.7 Central & South America Neurological Biomarkers Forecast
    12.8 Middle East and Africa Neurological Biomarkers Forecast
 
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators
 
14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Neurological Biomarkers Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors
 
15 Research Findings and Conclusion
 
16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
Read More
List of Tables and Figures
 
    Figure Neurological Biomarkers Product Picture
    Table Neurological Biomarkers Market Segments
    Table Key Manufacturers Neurological Biomarkers Covered
    Table Global Neurological Biomarkers Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
    Figure Global Neurological Biomarkers Sales Market Share by Product 2014-2025
    Figure Proteomics Product Picture
    Table Major Manufacturers of Proteomics
    Figure Genomics Product Picture
    Table Major Manufacturers of Genomics
    Figure Imaging Product Picture
    Table Major Manufacturers of Imaging
    Figure Bioinformatics Product Picture
    Table Major Manufacturers of Bioinformatics
    Figure Others Product Picture
    Table Major Manufacturers of Others
    Table Global Neurological Biomarkers Market Size Growth Rate by End User 2019-2025 (K Units)
    Figure Diagnostics
    Figure Drug Discovery
    Figure Personalized Medicine
    Figure Others
    Figure Neurological Biomarkers Report Years Considered
    Figure Global Neurological Biomarkers Market Size 2014-2025 (Million US$)
    Figure Global Neurological Biomarkers Sales 2014-2025 (K Units)
    Table Global Neurological Biomarkers Market Size by Regions 2014-2019 (K Units) & (Million US$)
    Table Global Neurological Biomarkers Sales by Regions 2014-2019 (K Units)
    Table Global Neurological Biomarkers Sales Market Share by Regions 2014-2019
    Figure Global Neurological Biomarkers Sales Market Share by Regions 2014-2019
    Figure 2018 Global Neurological Biomarkers Sales Market Share by Regions
    Table Global Neurological Biomarkers Revenue by Regions 2014-2019 (Million US$)
    Table Global Neurological Biomarkers Revenue Market Share by Regions 2014-2019
    Figure Global Neurological Biomarkers Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Neurological Biomarkers Revenue Market Share by Regions
    Table Global Neurological Biomarkers Sales by Manufacturers (2014-2019) (K Units)
    Table Global Neurological Biomarkers Sales Share by Manufacturers (2014-2019)
    Figure Global Neurological Biomarkers Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Neurological Biomarkers Revenue by Manufacturers (2014-2019) (Million USD)
    Table Neurological Biomarkers Revenue Share by Manufacturers (2014-2019)
    Figure Neurological Biomarkers Value Share by Manufacturers in 2018
    Table Key Manufacturers Neurological Biomarkers Price (2014-2019) (USD/Unit)
    Table Neurological Biomarkers Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Neurological Biomarkers Product Type
    Table Date of International Manufacturers Enter into Neurological Biomarkers Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Neurological Biomarkers Sales by Product (2014-2019) (K Units)
    Table Global Neurological Biomarkers Sales Share by Product (2014-2019)
    Figure Global Neurological Biomarkers Sales Market Share by Product (2014-2019)
    Figure Global Neurological Biomarkers Sales Market Share by Product in 2018
    Table Global Neurological Biomarkers Revenue by Product (2014-2019) (Million US$)
    Table Global Neurological Biomarkers Revenue Share by Product (2014-2019)
    Figure Global Neurological Biomarkers Revenue Market Share by Product (2014-2019)
    Figure Global Neurological Biomarkers Revenue Market Share by Product in 2018
    Table Neurological Biomarkers Price by Product 2014-2019 (USD/Unit)
    Table Global Neurological Biomarkers Sales by End User (2014-2019) (K Units)
    Table Global Neurological Biomarkers Sales Share by End User (2014-2019)
    Figure Global Sales Neurological Biomarkers Market Share by End User (2014-2019)
    Figure Global Sales Neurological Biomarkers Market Share by End User in 2018
    Figure North America Neurological Biomarkers Sales Growth Rate 2014-2019 (K Units)
    Figure North America Neurological Biomarkers Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Neurological Biomarkers Sales by Countries (2014-2019) (K Units)
    Table North America Neurological Biomarkers Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Neurological Biomarkers Sales Market Share by Countries
    Table North America Neurological Biomarkers Revenue by Countries (2014-2019) (Million US$)
    Table North America Neurological Biomarkers Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Neurological Biomarkers Revenue Market Share by Countries
    Figure United States Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure United States Neurological Biomarkers Revenue Growth Rate (2014-2019) (K Units)
    Figure Canada Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Canada Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Mexico Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Neurological Biomarkers Sales by Product (2014-2019) (K Units)
    Table North America Neurological Biomarkers Sales Market Share by Product (2014-2019)
    Figure 2018 North America Neurological Biomarkers Market Share by Product
    Table North America Neurological Biomarkers Sales by End User (2014-2019) (K Units)
    Table North America Neurological Biomarkers Sales Market Share by End User (2014-2019)
    Figure 2018 North America Neurological Biomarkers Market Share by End User
    Figure Europe Neurological Biomarkers Sales Growth Rate 2014-2019 (K Units)
    Figure Europe Neurological Biomarkers Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Neurological Biomarkers Sales by Countries (2014-2019) (K Units)
    Table Europe Neurological Biomarkers Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Neurological Biomarkers Sales Market Share by Countries
    Table Europe Neurological Biomarkers Revenue by Countries (2014-2019) (Million US$)
    Table Europe Neurological Biomarkers Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Neurological Biomarkers Revenue Market Share by Countries
    Figure Germany Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Germany Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure France Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure UK Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Italy Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Russia Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Neurological Biomarkers Sales by Product (2014-2019) (K Units)
    Table Europe Neurological Biomarkers Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Neurological Biomarkers Market Share by Product
    Table Europe Neurological Biomarkers Sales by End User (2014-2019) (K Units)
    Table Europe Neurological Biomarkers Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Neurological Biomarkers Market Share by End User
    Figure Asia Pacific Neurological Biomarkers Sales Growth Rate 2014-2019 (K Units)
    Figure Asia Pacific Neurological Biomarkers Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Neurological Biomarkers Sales by Countries (2014-2019) (K Units)
    Table Asia Pacific Neurological Biomarkers Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Neurological Biomarkers Sales Market Share by Countries
    Table Asia Pacific Neurological Biomarkers Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Neurological Biomarkers Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Neurological Biomarkers Revenue Market Share by Countries
    Figure China Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure China Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Japan Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Korea Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure India Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Australia Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Indonesia Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Malaysia Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Philippines Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Thailand Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Vietnam Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Singapore Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Neurological Biomarkers Sales by Product (2014-2019) (K Units)
    Table Asia Pacific Neurological Biomarkers Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Neurological Biomarkers Market Share by Product
    Table Asia Pacific Neurological Biomarkers Sales by End User (2014-2019) (K Units)
    Table Asia Pacific Neurological Biomarkers Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Neurological Biomarkers Market Share by End User
    Figure Central & South America Neurological Biomarkers Sales Growth Rate 2014-2019 (K Units)
    Figure Central & South America Neurological Biomarkers Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Neurological Biomarkers Sales by Countries (2014-2019) (K Units)
    Table Central & South America Neurological Biomarkers Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Neurological Biomarkers Sales Market Share by Countries
    Table Central & South America Neurological Biomarkers Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Neurological Biomarkers Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Neurological Biomarkers Revenue Market Share by Countries
    Figure Brazil Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Brazil Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Argentina Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Neurological Biomarkers Sales by Product (2014-2019) (K Units)
    Table Central & South America Neurological Biomarkers Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Neurological Biomarkers Market Share by Product
    Table Central & South America Neurological Biomarkers Sales by End User (2014-2019) (K Units)
    Table Central & South America Neurological Biomarkers Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Neurological Biomarkers Market Share by End User
    Figure Middle East and Africa Neurological Biomarkers Sales Growth Rate 2014-2019 (K Units)
    Figure Middle East and Africa Neurological Biomarkers Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Neurological Biomarkers Sales by Countries (2014-2019) (K Units)
    Table Middle East and Africa Neurological Biomarkers Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Neurological Biomarkers Sales Market Share by Countries
    Table Middle East and Africa Neurological Biomarkers Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Neurological Biomarkers Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Neurological Biomarkers Revenue Market Share by Countries
    Figure GCC Countries Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure GCC Countries Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Turkey Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure Egypt Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Neurological Biomarkers Sales Growth Rate (2014-2019) (K Units)
    Figure South Africa Neurological Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Neurological Biomarkers Sales by Product (2014-2019) (K Units)
    Table Middle East and Africa Neurological Biomarkers Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Neurological Biomarkers Market Share by Product
    Table Middle East and Africa Neurological Biomarkers Sales by End User (2014-2019) (K Units)
    Table Middle East and Africa Neurological Biomarkers Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Neurological Biomarkers Market Share by End User
    Table Thermo Fisher Scientific Company Details
    Table Thermo Fisher Scientific Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Thermo Fisher Scientific Recent Development
    Table Merck Company Details
    Table Merck Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Merck Recent Development
    Table Quest Diagnostics Company Details
    Table Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Quest Diagnostics Recent Development
    Table Abbott Company Details
    Table Abbott Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Abbott Recent Development
    Table Roche Company Details
    Table Roche Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Roche Recent Development
    Table Illumina Company Details
    Table Illumina Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Illumina Recent Development
    Table Bio-Rad Laboratories Company Details
    Table Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Bio-Rad Laboratories Recent Development
    Table QIAGEN Company Details
    Table QIAGEN Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table QIAGEN Recent Development
    Table Myriad RBM Company Details
    Table Myriad RBM Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Myriad RBM Recent Development
    Table Cisbio Bioassays Company Details
    Table Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Cisbio Bioassays Recent Development
    Table Athena Diagnostics Company Details
    Table BGI Company Details
    Table Wuxi APP Company Details
    Table Aepodia Company Details
    Table Proteome Sciences Company Details
    Table Genewiz Company Details
    Table Global Neurological Biomarkers Sales Forecast by Regions 2019-2025 (K Units)
    Table Global Neurological Biomarkers Sales Market Share Forecast by Regions 2019-2025
    Table Global Neurological Biomarkers Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Neurological Biomarkers Revenue Market Share Forecast by Regions 2019-2025
    Table Global Neurological Biomarkers Sales Forecast by Product 2019-2025 (K Units)
    Table Global Neurological Biomarkers Sales Market Share Forecast by Product 2019-2025
    Table Global Neurological Biomarkers Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Neurological Biomarkers Revenue Market Share Forecast by Product 2019-2025
    Table Global Neurological Biomarkers Sales Forecast by End User 2019-2025 (K Units)
    Table Global Neurological Biomarkers Sales Market Share Forecast by End User 2019-2025
    Figure North America Neurological Biomarkers Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure North America Neurological Biomarkers Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Neurological Biomarkers Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Europe Neurological Biomarkers Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Neurological Biomarkers Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Asia Pacific Neurological Biomarkers Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Neurological Biomarkers Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Central & South America Neurological Biomarkers Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Neurological Biomarkers Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Middle East and Africa Neurological Biomarkers Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Neurological Biomarkers Value Chain
    Table Neurological Biomarkers Customers List
    Table Neurological Biomarkers Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
SIMILAR REPORTS
Global Biomarkers Market
0 Items
X
No items in the cart.
$0.0